The Real World Evidence Solutions Market is valued at US$ 39.2 billion in 2021 and is predicted to reach US$ 110 billion by the end of 2032 at a CAGR of 10%, according to the most recent analysis released by Future Market Insights.
The compound annual growth rate projected is much higher than the historical CAGR of 8.6%. Furthermore, the market is predicted to have a $67.2 billion absolute dollar opportunity over the following ten years.
From 2022 through 2032, the services category is estimated to provide a US$ 41 billion absolute dollar opportunity. The services category is predicted to account for the majority of the global market during this time period and to grow at a compound annual growth rate of 10.4%. The pharmaceutical and biotechnology industries are driving market expansion by increasing their use of real-world services. Most medical research use clinical data acquired during ongoing patient care or as part of a formal clinical trial programme as a source of knowledge.
A move from volume-based to value-based care, favourable government policies, higher R&D expenditure, and a growing emphasis on end-to-end RWE services are driving the global market. By the end of 2032, the Global Market for Real World Evidence Solutions will be valued US$ 110 billion. Furthermore, a growing emphasis on personalised healthcare, an increase in the frequency of chronic diseases, an ageing population, and regulatory support for RWE solution adoption are projected to drive market expansion.
Market Segments Covered in Real World Evidence Solutions Market Study:
By Component:
- Services
- Data Sets
- Clinical Settings Data
- Claims Data
- Pharmacy data
- Patient-powered Data
By Application:
- Reimbursement/Coverage & Regulatory Decision Making
- Drug Development & Approvals
- Medical Device Development & Approvals
- Post Market Safety & Adverse Events Monitoring
By End-user:
- Healthcare payers
- Pharmaceutical & Medical Device Companies
- Healthcare Providers
- Other End-users
Browse More@ https://www.futuremarketinsights.com/reports/real-world-evidence-solutions-market
The key competitors in the Real World Evidence Solutions Market are –
- Cegedim Health Data
- IBM
- Icon Plc.
- IQVIA
- Medpace
- Oracle
- Parexel International Corp.
- PerkinElmer, Inc.
- PPD, Inc.
- Syneos Health
